This webinar hosted by American Osteopathic Academy of Addiction Medicine through a Opioid Response Network STR-TA grant will present ways to incorporate telemedicine into treatment programming for substance use disorders, including how to evaluate and expand access to Medications for Addiction Treatment using telemedicine, types of telehealth provider settings, implementation of PCSS best practices and evolving barriers.
Recorded - 3/27/2020

The Coronavirus Preparedness and Response Supplemental Appropriations Act, 2020 enacted by Congress on March 6, 2020. As a result, this would allow broader use of and payment for telehealth services for Medicare beneficiaries during the emergency period as defined under the legislation. Also due to the COVID-19 national public health emergency, as of March 16, 2020, and continuing for as long as the designation of a public health emergency remains, DEA-registered practitioners may issues prescriptions for schedule II-V controlled substances to patients for whom they have not conducted an in-person medical evaluation providing certain other conditions are met. Furthermore, restrictions on where telemedicine may be practiced have been suspended. These recent emergency changes in telemedicine regulations open new opportunities in the assessment and treatment of opioid use disorder during these turbulent times.

This webinar, hosted by the American Osteopathic Academy of Addiction Medicine through a Opioid Response Network STR-TA grant, will discuss changes in regulations, present ways to incorporate telemedicine into your current practice of treating OUD in the time of social distancing and stay at home orders, and discuss how to get reimbursed for this service.

Funding for this initiative was made possible (in part) by grant no. 6H79TI080816 from SAMHSA. The views expressed in written conference materials or publications and by speakers and moderators do not necessarily reflect the official policies of the Department of Health and Human Services; nor does mention of trade names, commercial practices, or organizations imply endorsement by the U.S. Government.

Recorded 3/27/2020

William Morrone, DO, FAOAAM William Morrone, DO, MPH, DABAM, FACOFP & DAAPM, is Medical Director at Recovery Pathways, investigator in a naloxone distribution for Mid-Michigan, Medical Director of 35th Circuit Shiawassee County Drug Court, Associate Professor of Family and Community Medicine, Michigan State University for 18 years and was Program Director of Family Medicine at Synergy Medical Education Alliance and liaison in the Dept of Psychiatry. He is triple board certified by the American Board of Addiction Medicine, American College of Osteopathic Family Practitioners and the American Academy of Pain Management. Dr. Morrone was a Ruth Fox faculty for the 42nd ASAM 2011 Medical-Scientific Conference Washington DC and is an active addiction educator and social advocate in pain management. Dr. Morrone is Director of the Saginaw Chippewa Tribal Court & commissioner on the Governor’s Impaired Driving Commission 2017-2019; he is also Assistant Prof Johns Hopkins School of Nursing.

Julie Kmiec, DO, FAOAAM Julie Kmiec, DO, graduated from Western University of Health Sciences College of Osteopathic Medicine of the Pacific. She completed her general psychiatry residency training and addiction psychiatry fellowship at Western Psychiatric Institute and Clinic (WPIC) in Pittsburgh, PA. She is currently an Associate Professor of Psychiatry at the University of Pittsburgh School of Medicine. She is board certified in general and addiction psychiatry. Dr. Kmiec is the Medical Director of the Ambulatory Detoxification Program and Bridge Clinic, as well as the Narcotic Addiction Treatment Program. Her clinical interests include treatment of drug and alcohol withdrawal, prevention of overdose, and pharmacotherapy for the treatment of addictions. Dr. Kmiec’s research involves training healthcare professionals on the implementation of medications for opioid use disorder. She is the Immediate Past President of the American Osteopathic Academy of Addiction Medicine.